Consumer Information for: RELENZA
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
RELENZA is an antiviral medicine for the treatment of
influenza and for reducing the chance of getting the flu in
community and household settings.
RELENZA is not a substitute for the flu shot. You should
receive an annual flu shot according to guidelines on
immunization practices that your doctor can share with you
What influenza is:
The flu, or influenza, is an illness caused by a virus in your
respiratory tract. Although the flu virus stays in your
respiratory tract and is not carried by the blood, it can often
make you feel sick all over.
True influenza is often confused with:
- the common cold (also caused by viruses)
- infections caused by bacteria, which may require antibiotics.
If you have the flu – You might need to be in bed for several days. You probably feel terrible. You will often have a fever, plus some or all of these symptoms:
- Chills
- Muscle aches
- Headache
- Sore throat
- Runny or stuffy nose
- Dry cough
- Tiredness
You might be surprised to find that you are still susceptible to flu even though you got your flu shot this year.
There are a few reasons why you may still have the flu:
- You were infected with the flu before the vaccine could protect you
- The flu vaccine did not completely protect you against
the virus because:
- the virus may have mutated or changed since the vaccine was developed
- you may have a weakened immune system
What it does
The influenza virus infects cells that line the inside of your
respiratory tract. When RELENZA is inhaled, it helps stop
the spread of the influenza virus to healthy cells in your
respiratory tract.
With less flu virus in your respiratory tract, you should
experience a less severe disease because your body’s defense
system doesn’t have to work too hard to fight the virus. That
means your flu symptoms should improve.
RELENZA should alleviate the symptoms you are feeling,
shorten the duration of your flu (i.e. reduces duration of flu
symptoms by about 1 or 2 days) and help you feel better
sooner.
RELENZA can also help reduce the chance of getting the flu
in persons who have a higher chance of getting the flu because
they spend time with someone who has the flu. RELENZA
can also reduce the chance of getting the flu if there is a flu
outbreak in the community.
When it should not be used
You should not take RELENZA if you are allergic to zanamivir or any component of the zanamivir inhalation powder (see section entitled “What the important nonmedicinal ingredients are”).
What the medicinal ingredient is
RELENZA contains the active ingredient zanamivir (zah-NAmih-veer)
What the non-medicinal ingredients are
RELENZA contains the nonmedicinal ingredient lactose (which contains milk protein).
What dosage form it comes in
RELENZA is a dry powder for inhalation. Each blister of RELENZA contains a dry loose powder mixture of zanamivir and lactose. The lactose acts as a carrier to deliver the medicine to the respiratory tract. The blister protects the powder from the air (until you inhale the powder). The DISKHALER® inhalation device is used to inhale RELENZA directly into your respiratory tract.
Warnings and precautions
Serious Warnings and Precautions
Some patients have had bronchospasm (wheezing) or
serious breathing problems when they used RELENZA.
Many but not all of these patients had asthma or chronic
obstructive pulmonary disease. There is limited data on
the use of RELENZA in patients with severe asthma or
severe chronic obstructive pulmonary disease. Therefore,
RELENZA is not generally recommended for such
patients.
If you develop worsening respiratory symptoms such as
wheezing or shortness of breath, stop using RELENZA
and contact your doctor right away.
If you have chronic respiratory disease such as asthma or
chronic obstructive pulmonary disease and your doctor
has prescribed RELENZA, you should have a fastacting,
inhaled bronchodilator available for your use. If
you are scheduled to use an inhaled bronchodilator at the
same time as RELENZA, use the inhaled bronchodilator
before using RELENZA.
Other kinds of infections can appear like influenza or
occur along with influenza and need different kinds of
treatment. Contact your doctor if you feel worse or
develop new symptoms during or after treatment, or if
your influenza symptoms do not start to get better.
BEFORE you use RELENZA talk to your doctor or pharmacist if:
-
you suffer from asthma or chronic respiratory
disease.
Similar to other non-bronchodilator medications that are inhaled as a dry powder, a bronchospasm can occur when using RELENZA and a fast-acting inhaled bronchodilator (e.g. salbutamol) should be available if this occurs. - you are pregnant, or likely to become pregnant soon, or if you are breast feeding. If you are pregnant or breast feeding, your doctor will help you decide whether you should take RELENZA.
- you have any type of chronic condition including lung or heart disease.
- you are allergic to lactose or milk protein.
Interactions with this medication
It is unlikely that RELENZA will interact with any medications you might be taking. Always be sure to tell your doctor what medications you are using.
Proper use of this medication
Usual Dose
For the Treatment of Influenza: You need to inhale two
blisters in the morning and two blisters in the evening. You
will use 1 ROTADISK® disk each day for 5 days. RELENZA
works best when you start taking it as soon as you begin to feel
symptoms and no later than 2 days after flu symptoms start.
Take the entire dosage (all 5 ROTADISK® disks) of
RELENZA even if you start to feel better before you’ve
finished all your medicine.
For the Prevention of Influenza: To reduce the chance of
getting the flu, the usual dose is two blisters once daily for 10
or 28 days as prescribed by your doctor.
If you are scheduled to use an inhaled bronchodilator at the
same time as RELENZA, you should use your bronchodilator
first, before using RELENZA.
See also section entitled “How to take RELENZA” for
instructions on how to use the DISKHALER® inhalation
device.
Overdose
Missed Dose
If you miss a dose, don’t worry. Take a dose as soon as you remember, except if it is near the next dose (within 2 hours). Then continue to take RELENZA at the usual times. You do not need to take a double dose. If you have missed several doses, inform your doctor or pharmacist and follow the advice given to you.
Side effects and what to do about them
Some patients have had breathing problems while taking
RELENZA. This can be very serious and needs treatment
right away. Most of the patients who had this problem had
asthma or COPD but some did not. If you have trouble
breathing or have wheezing after your dose of RELENZA,
stop taking RELENZA and seek medical attention
immediately.
In studies, the most common side effects during treatment
with RELENZA have been headaches, diarrhea, nausea,
vomiting, nasal irritation, bronchitis, cough, sinusitis, ear,
nose and throat infections and dizziness. Other side effects
that have been reported, but are not as common include
allergic reactions and rashes.
If you are feeling unwell when you take RELENZA you may
faint or become lightheaded after inhaling RELENZA. You
must sit down in a relaxed position before inhaling the dose of
RELENZA, and you must only hold your breath for as long
as is comfortable after inhaling the dose. If you are feeling
unwell, you are advised to have someone with you while you
are inhaling the dose of RELENZA.
People with influenza (the flu), particularly children and
adolescents, may be at an increased risk of seizures,
confusion, delirium, hallucinations, or abnormal behaviour
early in their illness. These events may occur after beginning
RELENZA or may occur when flu is not treated. These
events are uncommon but may result in accidental injury to
the patient. Therefore, patients should be observed for signs
of unusual behaviour and a healthcare professional should be
contacted immediately if the patient shows any signs of
unusual behaviour.
Please refer to the section entitled “Serious Warnings and
Precautions” and the table below for additional information.
Symptom / effect | Talk with your doctor or pharmacist only if severe | Talk with your doctor or pharmacist in all cases | Stop taking drug and call your doctor or pharmacist |
---|---|---|---|
Very rare | |||
Bronchospasm (involuntary contraction of the smooth muscles of the airway passages) with symptoms such as difficulty in breathing and wheezing. | ✔ | ✔ | |
Allergic reaction such as swelling of the face or in the mouth or throat; or itchy, raised skin rash (hives); or breathing problems (shortness of breath or wheezing), or collapse. | ✔ | ✔ | |
Skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme) | ✔ | ✔ | |
Widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens Johnson Syndrome) | ✔ | ✔ | |
Extensive peeling of the skin on much of the body surface (toxic epidermal necrolysis) | ✔ | ✔ |
If you notice any of the symptoms listed in the table above
stop taking RELENZA and contact a doctor urgently.
This is not a complete list of side effects. For any unexpected
effects while taking RELENZA, contact your doctor or
pharmacist.
How to store
Store at room temperature (15 to 30°C) in a dry place. Use
the ROTADISK® disk before the expiration date. Do not
puncture any RELENZA ROTADISK® disk blister until you
are ready to inhale a dose of RELENZA.
Keep RELENZA and the DISKHALER® inhalation device
in a safe place away from children.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhpmps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax;
- Calling toll-free at 1-866-234-2345.
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice
More information
This document plus the full product monograph, prepared for
health professionals can be found at:
http://www.gsk.ca or by contacting the sponsor,
GlaxoSmithKline Inc.
7333 Mississauga Road
Mississauga, Ontario
L5N 6L4
1-800-387-7374
This leaflet was prepared by GlaxoSmithKline Inc.
Last revised: July 20, 2018
© 2018 GSK Group of companies or its Licensor.
Trademarks are owned by or licensed to the GSK group of companies.
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
TEVA-KETOCONAZOLE | 02231061 | TEVA CANADA LIMITED | KETOCONAZOLE 200 MG |